• Molecular NameDicloxacillin
  • SynonymDiclossacillina [DCIT]; Dicloxacilin; Dicloxacilina [INN-Spanish]; Dicloxacillin Sodium; Dicloxacilline [INN-French]; Dicloxacillinum [INN-Latin]; Dicloxacycline
  • Weight470.333
  • Drugbank_IDDB00485
  • ACS_NO3116-76-5
  • Show 3D model
  • LogP (experiment)2.91
  • LogP (predicted, AB/LogP v2.0)3.12
  • pka2.8
  • LogD (pH=7, predicted)-0.84
  • Solubility (experiment)0.00363 mg/ml
  • LogS (predicted, ACD/Labs)(ph=7)-1.39
  • LogSw (predicted, AB/LogsW2.0)0.07
  • Sw (mg/ml) (predicted, ACD/Labs)0.09
  • No.of HBond Donors2
  • No.of HBond Acceptors8
  • No.of Rotatable Bonds4
  • TPSA138.04
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyA narrow spectrum beta-lactam antibiotic of the penicillin class. It is used to treat infections caused by susceptible Gram-positive bacteria. Notably, it is active against beta-lactamase-producing organisms such as Staphylococcus aureus
  • Absorption_valueN/A
  • Absorption (description)Absorption of the isoxazolyl penicillins after oral administration is rapid but incomplete: peak blood levels are achieved in 1-1.5 hours. Oral absorption of cloxacillin, dicloxacillin, oxacillin and nafcillin is delayed when the drugs are administered after meals.
  • Caco_2N/A
  • Bioavailability67.5
  • Protein binding95.8
  • Volume of distribution (VD)0.086 L/kg
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmHepatic
  • Half life0.7 h
  • ExcretionRenal and biliary
  • Urinary Excretion60
  • Clerance1.6 ml/min/kg
  • ToxicityN/A
  • LD50 (rat) 3579 mg/kg
  • LD50 (mouse)N/A